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Introduction
Particular interest has been shown in 'short' noradrenergic neurones (Owman & Sjöstrand, 1965; Sjöstrand, 1965) since they apparently share a number of properties, apart from the length of their aeon, which differ considerably from those of ordinary 'long' noradrenergic neurones (see Owman, Sjöberg & Sjöstrand, 1974) . For example, they are more resistant to damage by 6-hydroxydopamine (Malmfors & Sachs, 1968) , depletion of noradrenaline stores after reserpine (Sjöstrand & Swedin, 1968) or a-methyl-p-tyrosine (Swedin, 1970) and inhibition of development by anti-nerve growth factor (Hamberger, Levi-Montalcini, Norberg & Sjöqvist, 1965) . On the basis of such results it has been suggested that 'short' noradrenergic neurones constitute a distinct neuronal type. However, most of these studies were carried out using male animals and the 'short' noradrenergic neurones which innervate the male, and part of the female internal genitaUa have been shown to differ. Whereas oestrogen and progesterone markedly influence the noradrenaline content of female 'short' noradrenergic neurones (Sjöberg, 1968a, b; Falck, Owman, Rosengren & Sjöberg, 1969a, b) , they have no effect on the noradrenaline content of male 'short' noradrenergic neurones (Owman, Sjöberg, Sjöstrand & Swedin, 1970) .
In male rats and mice the 'short' noradrenergic innervation has been shown to be considerably more sensitive to damage by chronic guanethidine treatment than 'long' noradrenergic neurones (Gannon, Iwayama, Burnstock, Gerkens & Mashford, 1971; Evans, Iwayama & Burnstock, 1973; Evans, Heath & Burnstock, 1979a) . The purpose of this study was to investigate the effects of chronic treatment with low and high doses of guanethidine, a drug used widely in the treatment of hypertension, on the peripheral noradrenergic neurones of the female rat and particularly to see whether the 'short' noradrenergic neurones are affected earlier or with lower doses. The possibihty of damage to fetal noradrenergic neurones as a result of maternally administered guanethidine was also investigated.
Materials and Methods
Thirty-five (35) (Falck & Owman, 1965) , as described in detaü elsewhere (Evans et al., 1973) , was carried out on the following tissues: right atrium, superior cervical ganghon, iris, coeliac ganglion, ovary, oviduct, uterus, vagina, paracervical ganglion, urethra and ureter. Using light-field iUumination it is possible to identify the presence of intact non-fluorescent nerve cell bodies in sympathetic ganglia. The absence of such cells and the continued lack of fluorescence many weeks after cessation of treatment were taken to indicate that degeneration of the noradrenergic neurones had taken place. The validity of this belief has been shown in other studies Heath et al, 1972; Evans et al., 1979b) using Ught and electron microscopy.
Another group of 9 virgin female rats were injected with 25, 10 or 1 mg guanethidine/kg/day for 2 weeks before mating with normal males. The injections were continued without interruption until the end of pregnancy. The male offspring were killed 1, 2 and 10 weeks after birth and tissue from the right atrium, superior cervical gangUon, ileum, vas deferens, epididymis and pelvic plexus was prepared for fluorescence histochemistry. Male offspring were examined since the 'short' noradrenergic neurones supplying the male reproductive tract have been shown to be particularly sensitive to low doses of guanethidine Evans et al, 1972 Evans et al, , 1973 . One vas deferens from the 10-week-old males was reserved for organ bath experiments where the response to stimulation of intramural nerves and sensitivity to noradrenaline were determined. The conditions and experimental procedure were as described elsewhere (Evans et al, 1973 (Burnstock, Evans, Gannon, Heath & James, 1971) in which similar treatment produced a widespread sympathectomy involving the degeneration of over 95% of peripheral noradrenergic neurones in both male and female rats. The reinnervation of these tissues after cessation of treatment was the same as seen in male rats and is described in detail elsewhere (Evans et al, 1979b) .
The normal paracervical gangUon is a diffuse ganglion in which only a small proportion (between 20 and 30%) of the nerve ceU bodies show weak to moderate fluorescence (PL 3, Fig. 20) . The remainder are non-fluorescent presumably cholinergic ceUs (see also Adham & Schenk, 1969; Kanerva, 1972a, b The fluorescent innervation to the reproductive organs and urethra had decreased greatly after treatment for 1 week. A few fibres were seen in the isthmus of the oviduct (PL 1, Fig. 7 ) and in the vagina (PL 2, Fig. 15 ) but virtually no fibres were seen in the uterus (PL 2, Fig. 11 The noradrenergic innervation appears normal. Sjöstrand, 1965; Owman & Sjöstrand, 1965) that the noradrenergic innervation of the male internal genital organs arises in the peripherally located pelvic plexus (hypogastric ganglion). These neurones were described as 'short' noradren¬ ergic neurones to reflect the shorter length of their post-ganglionic axons.
Studies investigating the origin of the noradrenergic innervation of female internal genitalia in a number of mammalian species including the rat, rabbit, cat and guinea-pig (Brundin, 1965; Norberg & Fredricsson, 1966; Owman, Rosengren & Sjöberg, 1966; Rosengren & Sjöberg, 1967; Sjöberg, 1967; Marshall, 1970; Kanerva, 1972a, b; Kulkarni, Wakade & Kirpekar, 1976) Text- fig. 3 . Mean log concentration-response curves for noradrenaline of vasa deferentia from the 10-week-old offspring of untreated female rats (-) and of female rats treated with guane¬ thidine (25 mg/kg/day) (-) Sjöberg, 1967) . In the rat the innervation pattern appears to be as follows. The ovary is sparsely innervated by 'long' noradrenergic neurones. The oviduct, particularly in the isthmus, has a relatively dense noradrenergic terminal network which arises in roughly equal proportions from both 'long' and 'short' noradrenergic neurones. The sparse noradrenergic innervation of the uterus and relatively dense innervation of the vagina arise largely from 'short' noradrenergic neurones. 'Short' noradrenergic neurones are also believed to innervate the trigonium region of the urinary bladder (Hamberger & Norberg, 1965a, b) and the urethra (Owman, Owman & Sjöberg, 1971) . 'Long' noradrenergic neurones innervate the blood vessels to these organs.
Whereas male 'short' noradrenergic neurones are selectively and permanently damaged by chronic treatment with low doses of guanethidine (Evans et al, , 1973 , female 'short' noradrenergic neurones show no such damage. This striking difference indicates a major difference between male and female 'short' noradrenergic neurones. It is clearly incorrect to consider that male and female 'short' noradrenergic neurones have comparable properties without experimental verification. As mentioned earlier female, but not male, 'short' noradrenergic neurones are affected by oestrogen and progesterone. Also, it is not possible to produce a complete noradrenergic denervation of male internal genitaüa with 6-hydroxydopamine, even when it is injected into newborn animals (Jaim-Etcheverry & Zieher, 1971) . However, noradrenergic denervation of female internal genitalia can be achieved by injection of 6-hydroxydopamine into adult female rabbits (Hervonen & Kanerva, 1974 (Evans, 1979) . The effects of 6-hydroxydopamine on the 'long' noradrenergic fibres of various systems also vary greatly. Gillespie & McGrath (1972 found that the 'long' noradrenergic innervation of the anococcygeus muscle and the 'short' noradrenergic innervation of the vas deferens were equally resistant to depletion by reserpine but that the 'long' noradrenergic innervation of the heart was depleted to a much greater extent.
Although it is, at times, convenient to use abbreviations such as 'short' and 'long' to refer to neurone groups it is important to realize that these are generally artificial categories super¬ imposed on natural biological diversity. Even as an anatomical description of the length of the post-ganglionic axon the terms 'long' and 'short' are not precise. The 'short' axons which pass from the pelvic plexus along the length of the vas deferens to innervate the cauda epididymidis would be considerably longer than many 'long' axons which innervate organs and blood vessels in the vicinity of the pre-and paravertebral sympathetic ganglia.
Decentralisation of 'long' noradrenergic neurones increases their susceptibility to damage by guanethidine and it has been suggested that the selective damage of 'short' noradrenergic neurones in male rats by low doses of guanethidine is related to the low levels of physiological activity in these nerves (Evans, 1979) . Since guanethidine is released on nerve stimulation as a "false transmitter" (Boullin, Costa & Brodie, 1966 ) the tonic activity of many 'long' noradren¬ ergic neurones may sufficiently reduce neuronal levels of guanethidine so as to prevent damage by low doses of the drug. As to the 'short' noradrenergic neurones in females, their physiological role is not well understood (Brundin, 1965; MarshaU, 1970) ; however, their normal physiological activity may be sufficient to reduce intraneuronal levels of guanethidine and prevent neuronal damage. Furthermore, the noradrenergic innervation of the vagina and uterus, as revealed by fluorescence histochemistry, is considerably more dense and prominent during oestrus than during dioestrus and this has been attributed to a cycUcal depletion and repletion of noradren¬ aline during the 4-day oestrous cycle of the rat (Adham & Schenk, 1969) . Since guanethidine acts as a false transmitter these cyclical changes in transmitter content are likely to be paralleled by cyclical changes in guanethidine content which would lessen the overall accumulation of guanethidine during chronic treatment.
Alternatively the difference in guanethidine sensitivity of male and female 'short' noradrenergic neurones may be due to other metabolic differences between these two cell groups.
Such an explanation has been proposed to explain why noradrenaline levels of female, but not male 'short' noradrenergic neurones are markedly influenced by oestrogen and progesterone (Owman et al, 1970) . The lack of effect of guanethidine on the noradrenergic innervation of the vagina, uterus and oviduct might be interpreted to suggest that, in the rat, none of these organs is innervated by 'short' noradrenergic neurones. However, the cell bodies of the 'short' noradrenergic neurones were examined and these also were clearly undamaged by low doses of guanethidine.
No information is avaUable in the literature regarding the occurrence or extent of placental transfer of guanethidine. If guanethidine is able to cross the placental barrier, then chronic treatment of pregnant rats may result in damage to the developing adrenergic nervous system of offspring. The immature sympathetic neurones of newborn animals are particularly vulnerable to a number of adrenolytic drugs, including guanethidine (Angeletti & Levi-Montalcini, 1970 Eränkö & Eränkö, 1971a, b) .
Typical extensive degeneration of the maternal adrenergic nervous system occurred after treatment of female rats with a high dose of guanethidine before and throughout pregnancy. However, the damage to the adrenergic nervous system of their offspring was much less extensive. While there was a transient 50% reduction in fluorescence levels there was no indication of degeneration of noradrenergic neurones. Slight differences were also seen in off¬ spring from rats treated with 10 mg guanethidine/kg/day. This suggests that either very little of the guanethidine is crossing the placental barrier or that noradrenergic neurones are not susceptible during prenatal development to the degenerating effects of the drug. (Johns, Clumecky & Paton, 1974) , particularly in relation to the postulated role of an adrenergic sphincter mechanism in the isthmus of the oviduct (Brundin, 1965 (Brundin, , 1969 Pauerstein, Hodgson & Kramen, 1974) . Contrary to the suggestion of Kanerva & Hervonen (1976) , it would appear that an intact adrenergic innervation is also not essential for transport of spermatozoa in the female tract, transport and spacing of embryos before implantation, for maintenance of pregnancy or for parturition.
